FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
FDA draft guidance aims to reduce unnecessary animal testing in nonclinical safety assessments for certain cancer drugs, potentially accelerating timelines for human trials.
FDA Finalizes Food Chemical Safety Program, Launches Reassessment of BHT and ADA
FDA finalized its post-market assessment program for food chemicals and launched reassessments of BHT and ADA.
FDA Advances Drug Repurposing to Address Unmet Medical Needs
FDA is soliciting public input on drug repurposing to accelerate treatments for chronic and rare diseases.
FDA Intensifies Efforts to Import Lower-Cost Drugs
FDA Intensifies Efforts with States to Import Lower-Cost Canadian Drugs.
Showing 22 to 22 of 22 results